HCU Research Grants
HCU Network America provides grants to researchers to support the key priorities identified via our research strategy. These grants are primarily administered via a global grants process that may be a collaborative effort with HCU Network Australia or with other patient groups or funded solely through HCU Network America.
Research grants are intended to support innovative seed or pilot projects to produce preliminary data that would facilitate more substantial funding from federal agencies, foundations, or corporations.
2026 EOI: HCU Network America issued a call in March 2026 for Expressions of Interest (EOI) for research grants to address one of the following priorities:
- Novel proposals for treatment and prevention of clinical manifestations for Classical Homocystinuria and/or;
- Novel proposals for treatment and prevention of clinical manifestations for Cobalamin G, a Methionine Synthase deficiency, by exploring novel mechanisms to obtain proof of concept to enable progression to clinical trials.
Important Dates:
- EOI deadline for submission: May 31, 2026
- Notification of successful EOI: July 1, 2026
- Deadline for full applications: August 31, 2026
- Funding decisions will be made by October 31, 2026
Scientific Advisory Board
Professor Warren Kruger, (Co-Chair); Ph. D, Full professor, Cancer Biology and Epigenetics program at Fox Chase Cancer Center, Philadelphia, PA, U.S. Read Professor Kruger's bio
Peter Baker, (Co-Chair); MD. Clinical Biochemical Genetics, Pediatrics. Colorado Children's Hospital. Read Dr. Baker's bio
Dr Andrew Morris, BM, BCh, PhD, Consultant and Senior Lecturer in Paediatric Metabolic Medicine, Willink Metabolic Unit, Manchester University Hospitals NHS Trust, UK. Read Dr. Morris' bio
Professor Matthias R. Baumgartner, Prof. Dr. med., head of Division for Metabolic Diseases and Medical Director of the Swiss Newborn Screening Program, University Children’s Hospital Zurich, Zürich, Switzerland. Read Professor Baumgartner's bio
Dr. Kaustuv Bhattacharya, MBBS, MRCP, MRCPCH, MD, FRACP, Ireland
Dr Kimberly Chapman, MD, Ph.D., Attending physician at Children's Hospital Los Angeles and professor of clinical pediatrics at Keck School of Medicine of USC, California. Read Dr. Chapman's bio
Professor Viktor Kožich, MD, PhD, Professor of Medical Genetics,
Department of Pediatrics and Inherited Metabolic Diseases, General University Hospital in Prague and Charles University-First Faculty of Medicine, Prague, Czech Republic. Read Professor Kožich’s bio
Sean Froese, PD. Principle Investigator, Division of Metabolism, University Children’s Hospital Zurich, Switzerland. Read his bio
Walla Al-Hertaini, MD, MS, FRCPC, FCCMG, FACMG.Chief of the Metabolic Disorders Division and Medical Director of Metabolic Disorders at Children’s Hospital of Orange County. Read her bio
Manuel Schiff. Assistance Publique Hospitaux de Paris-University Hospital Robert-Debra, France. Associate professor of Pediatrics. Head of the Reference Centre for Inborn Errors of Metabolism. Read his bio
David Rosenblatt, MD. McGill University. Dodd Q. Chu and Family Chair in Medical Genetics Professor, Departments of Human Genetics, Medicine, Pediatrics and Biology. Read his bio
Nicola Longo, MD PhD. Clinical Genetics at UCLA, California. Read his bio
Patient Representatives:
Brittany Parke. HCU Network America, Research Coordinator
Grace Talbert. HCU Network America, Severe MTHFR Committee Chair
Margaret McGlynn, R. Ph., Ph. D. (hon), President of Board, HCU Network America
Tara Morrison, BA LLB, Director and Chair, HCU Network Australia
Melanie Colter, Can PKU+ Board Member, HCU Representative, Parent to Masen, Classical HCU
For more information, email Brittany Parke at research@hcunetworkamerica.org
